• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微波消融后Lewis肺癌小鼠模型肿瘤引流淋巴结免疫微环境的动态变化

Dynamic Changes in the Immune Microenvironment in Tumor-Draining Lymph Nodes of a Lewis Lung Cancer Mouse Model After Microwave Ablation.

作者信息

Sang Jing, Liu Peng, Wang Meixiang, Xu Fengkuo, Ma Ji, Wei Zhigang, Ye Xin

机构信息

Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Jinan, People's Republic of China.

Department of Pathology, The Affiliated Taian City Central Hospital of Qingdao University, Taian, People's Republic of China.

出版信息

J Inflamm Res. 2024 Jul 1;17:4175-4186. doi: 10.2147/JIR.S462650. eCollection 2024.

DOI:10.2147/JIR.S462650
PMID:38979433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11228081/
Abstract

PURPOSE

Microwave ablation (MWA) is a minimally invasive technique for treating lung cancer. It can induce immune response; however, its effect on the immune microenvironment in tumor-draining lymph nodes (TdLN) is not well understood. This study aims to identify changes in the immune microenvironment in TdLN following MWA in a Lewis lung cancer (LLC) mouse model.

METHODS

LLC mouse model was established and followed by MWA. TdLN were collected at various time points, including pre-MWA and days 1, 2, 4, and 8 post-MWA. Flow cytometry was used to determine the frequencies of CD4 T cells, CD8 T cells, regulatory T (Treg) cells, natural killer (NK) cells, dendritic cells (DCs) and other immune cells in the TdLN. Certain cytokines were also detected.

RESULTS

Compared with pre-MWA, the frequency of CD4 T cells significantly increased from day 1 to day 8 post-MWA. The frequency of CD8 T cells decreased significantly on days 2 and 4, but no significant changes occurred on days 1 and 8. Significant decreases in the frequencies of Treg cells and Klrg1 Treg cells were observed from day 1 to day 4. On days 4 and 8, there was a significant increase in the frequency of NK cells. The frequency of resident cDC2 significantly increased on day 4, whereas CD11b migratory cDCs increased on day 1. Additionally, on day 4, a notable rise was observed in the frequency of NK cells secreting IFN-γ, while on day 8, there was a significant increase in the frequency of CD8 T cells secreting both IFN-γ and TNF-α.

CONCLUSION

MWA of lung cancer can alter the immune microenvironment in the TdLN, triggering immune responses. These changes are particularly evident and intricate within the initial 4 days post-MWA. Treatment combined with MWA within a certain period may significantly enhance anti-tumor immunity.

摘要

目的

微波消融(MWA)是一种治疗肺癌的微创技术。它可诱导免疫反应;然而,其对肿瘤引流淋巴结(TdLN)中免疫微环境的影响尚不清楚。本研究旨在确定Lewis肺癌(LLC)小鼠模型中MWA后TdLN免疫微环境的变化。

方法

建立LLC小鼠模型并进行MWA。在包括MWA前以及MWA后第1、2、4和8天等不同时间点收集TdLN。采用流式细胞术测定TdLN中CD4 T细胞、CD8 T细胞、调节性T(Treg)细胞、自然杀伤(NK)细胞、树突状细胞(DC)及其他免疫细胞的频率。还检测了某些细胞因子。

结果

与MWA前相比,MWA后第1天至第8天CD4 T细胞频率显著增加。CD8 T细胞频率在第2天和第4天显著降低,但在第1天和第8天无显著变化。从第1天到第4天观察到Treg细胞和Klrg1 Treg细胞频率显著降低。在第4天和第8天,NK细胞频率显著增加。驻留cDC2频率在第4天显著增加,而CD11b迁移性cDC在第1天增加。此外,在第4天,分泌IFN-γ的NK细胞频率显著升高,而在第8天,分泌IFN-γ和TNF-α的CD8 T细胞频率显著增加。

结论

肺癌的MWA可改变TdLN中的免疫微环境,引发免疫反应。这些变化在MWA后最初4天内尤为明显和复杂。在一定时期内联合MWA治疗可能显著增强抗肿瘤免疫力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e98f/11228081/5f9ba1671ef0/JIR-17-4175-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e98f/11228081/61b3b286b08e/JIR-17-4175-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e98f/11228081/a6630c9907e7/JIR-17-4175-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e98f/11228081/f846d5af8adf/JIR-17-4175-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e98f/11228081/2d0682c10608/JIR-17-4175-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e98f/11228081/5f9ba1671ef0/JIR-17-4175-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e98f/11228081/61b3b286b08e/JIR-17-4175-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e98f/11228081/a6630c9907e7/JIR-17-4175-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e98f/11228081/f846d5af8adf/JIR-17-4175-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e98f/11228081/2d0682c10608/JIR-17-4175-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e98f/11228081/5f9ba1671ef0/JIR-17-4175-g0005.jpg

相似文献

1
Dynamic Changes in the Immune Microenvironment in Tumor-Draining Lymph Nodes of a Lewis Lung Cancer Mouse Model After Microwave Ablation.微波消融后Lewis肺癌小鼠模型肿瘤引流淋巴结免疫微环境的动态变化
J Inflamm Res. 2024 Jul 1;17:4175-4186. doi: 10.2147/JIR.S462650. eCollection 2024.
2
Microwave ablation enhances the systemic immune response in patients with lung cancer.微波消融增强肺癌患者的全身免疫反应。
Oncol Lett. 2024 Jan 18;27(3):106. doi: 10.3892/ol.2024.14239. eCollection 2024 Mar.
3
Enhanced antitumor efficacy through microwave ablation combined with a dendritic cell-derived exosome vaccine in hepatocellular carcinoma.微波消融联合树突状细胞来源的外泌体疫苗增强肝癌的抗肿瘤疗效。
Int J Hyperthermia. 2020;37(1):1210-1218. doi: 10.1080/02656736.2020.1836406.
4
Profile of regulatory T cells and interferon γ secretion in the tumor-draining lymph node from mouse Hepa1-6 cells.肿瘤引流淋巴结中调节性 T 细胞和干扰素 γ 分泌的特征:来自 Hepa1-6 细胞的小鼠模型。
J Surg Res. 2013 Aug;183(2):900-6. doi: 10.1016/j.jss.2013.02.001. Epub 2013 Feb 24.
5
Microwave ablation of primary breast cancer inhibits metastatic progression in model mice via activation of natural killer cells.微波消融原发性乳腺癌通过激活自然杀伤细胞抑制模型小鼠的转移进展。
Cell Mol Immunol. 2021 Sep;18(9):2153-2164. doi: 10.1038/s41423-020-0449-0. Epub 2020 May 8.
6
Microwave ablation combined with OK-432 induces Th1-type response and specific antitumor immunity in a murine model of breast cancer.在小鼠乳腺癌模型中,微波消融联合溶链菌制剂可诱导Th1型反应和特异性抗肿瘤免疫。
J Transl Med. 2017 Jan 31;15(1):23. doi: 10.1186/s12967-017-1124-9.
7
Immune landscape in vulvar cancer-draining lymph nodes indicates distinct immune escape mechanisms in support of metastatic spread and growth.外阴癌引流淋巴结中的免疫景观表明了不同的免疫逃逸机制,这些机制支持转移的扩散和生长。
J Immunother Cancer. 2021 Oct;9(10). doi: 10.1136/jitc-2021-003623.
8
Selective changes in the immune profile of tumor-draining lymph nodes after different neoadjuvant chemoradiation regimens for locally advanced cervical cancer.局部晚期宫颈癌新辅助放化疗后肿瘤引流淋巴结免疫特征的选择性变化。
Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1546-53. doi: 10.1016/j.ijrobp.2009.10.014.
9
Study on Changes in Immune Function After Microwave Ablation of Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌微波消融术后免疫功能变化的研究
Cancer Manag Res. 2022 Sep 21;14:2861-2868. doi: 10.2147/CMAR.S358649. eCollection 2022.
10
Landscape of the Peripheral Immune Response Induced by Local Microwave Ablation in Patients with Breast Cancer.局部微波消融诱导乳腺癌患者外周免疫反应的特征。
Adv Sci (Weinh). 2022 Jun;9(17):e2200033. doi: 10.1002/advs.202200033. Epub 2022 Apr 11.

引用本文的文献

1
Ablation combined with video-assisted thoracic surgery hybrid technique for multiple primary lung cancer.消融联合电视辅助胸腔镜手术杂交技术治疗多原发性肺癌
iScience. 2025 May 20;28(6):112703. doi: 10.1016/j.isci.2025.112703. eCollection 2025 Jun 20.
2
Interventional oncology and immunotherapy: current status and future perspectives.介入肿瘤学与免疫疗法:现状与未来展望
Front Immunol. 2025 Apr 8;16:1541105. doi: 10.3389/fimmu.2025.1541105. eCollection 2025.
3
Microwave ablation combined with immune checkpoint inhibitor enhanced the antitumor immune activation and memory in rechallenged tumor mouse model.

本文引用的文献

1
Potential biomarkers for predicting immune response and outcomes in lung cancer patients undergoing thermal ablation.预测肺癌患者接受热消融治疗后免疫反应和结局的潜在生物标志物。
Front Immunol. 2023 Nov 1;14:1268331. doi: 10.3389/fimmu.2023.1268331. eCollection 2023.
2
Ablation of Stage I-II Non-Small Cell Lung Cancer in Patients With Interstitial Lung Disease: A Multicenter Retrospective Study.间质性肺疾病患者 I 期- II 期非小细胞肺癌的消融治疗:一项多中心回顾性研究。
AJR Am J Roentgenol. 2024 Feb;222(2):e2330300. doi: 10.2214/AJR.23.30300. Epub 2023 Nov 15.
3
Dendritic cells as shepherds of T cell immunity in cancer.
微波消融联合免疫检查点抑制剂增强了再激发肿瘤小鼠模型中的抗肿瘤免疫激活和记忆。
Cancer Immunol Immunother. 2025 Mar 25;74(5):161. doi: 10.1007/s00262-025-04003-5.
4
Discrepancies in PD-L1 expression, lymphocyte infiltration, and tumor mutational burden in non-small cell lung cancer and matched brain metastases.非小细胞肺癌及其匹配的脑转移瘤中程序性死亡受体配体1(PD-L1)表达、淋巴细胞浸润和肿瘤突变负荷的差异
Transl Lung Cancer Res. 2024 Dec 31;13(12):3590-3602. doi: 10.21037/tlcr-24-735. Epub 2024 Dec 27.
树突状细胞作为癌症中 T 细胞免疫的牧羊人。
Immunity. 2023 Oct 10;56(10):2218-2230. doi: 10.1016/j.immuni.2023.08.014. Epub 2023 Sep 13.
4
Microwave ablation for the treatment of peripheral ground-glass nodule-like lung cancer: Long-term results from a multi-center study.微波消融治疗周围磨玻璃结节样肺癌:多中心研究的长期结果。
J Cancer Res Ther. 2023 Aug;19(4):1001-1010. doi: 10.4103/jcrt.jcrt_1436_23.
5
CD4 T cell memory.CD4 T 细胞记忆。
Nat Immunol. 2023 Jun;24(6):903-914. doi: 10.1038/s41590-023-01510-4. Epub 2023 May 8.
6
Temperature sensitive liposome based cancer nanomedicine enables tumour lymph node immune microenvironment remodelling.基于温度敏感脂质体的癌症纳米医学可实现肿瘤淋巴结免疫微环境重塑。
Nat Commun. 2023 Apr 19;14(1):2248. doi: 10.1038/s41467-023-38014-6.
7
CD4 T cells in cancer.癌症中的 CD4 T 细胞。
Nat Cancer. 2023 Mar;4(3):317-329. doi: 10.1038/s43018-023-00521-2. Epub 2023 Mar 9.
8
Checkpoint TIPE2 Limits the Helper Functions of NK Cells in Supporting Antitumor CD8 T Cells.检查点 TIPE2 限制 NK 细胞在支持抗肿瘤 CD8 T 细胞中的辅助功能。
Adv Sci (Weinh). 2023 Apr;10(12):e2207499. doi: 10.1002/advs.202207499. Epub 2023 Feb 19.
9
Immunogenic change after percutaneous microwave ablation in pulmonary malignancies: Variation in immune cell subsets and cytokines in peripheral blood.经皮微波消融治疗肺部恶性肿瘤后的免疫原性变化:外周血中免疫细胞亚群和细胞因子的变化。
Front Immunol. 2022 Dec 9;13:1069192. doi: 10.3389/fimmu.2022.1069192. eCollection 2022.
10
In vivo growth of subclones derived from Lewis lung carcinoma is determined by the tumor microenvironment.源自Lewis肺癌的亚克隆在体内的生长由肿瘤微环境决定。
Am J Cancer Res. 2022 Nov 15;12(11):5255-5270. eCollection 2022.